Geode Capital Management
BLTE icon

Geode Capital Management’s Belite Bio BLTE Stock Holding History

Geode Capital Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.33M Sell
19,596
-3,044
-13% -$494K ﹤0.01% 3030
2026
Q2 		$3.49M Buy
22,640
+12,213
+117% +$1.87M ﹤0.01% 3056
2026
Q1 		$1.66M Sell
10,427
-18
-0.2% -$3.03K ﹤0.01% 3192
2025
Q4 		$1.67M Sell
10,445
-5,180
-33% -$614K ﹤0.01% 3224
2025
Q3 		$1.16M Buy
15,625
+2,761
+21% +$181K ﹤0.01% 3341
2025
Q2 		$742K Buy
12,864
+111
+0.9% +$6.77K ﹤0.01% 3426
2025
Q1 		$845K Buy
12,753
+6,053
+90% +$365K ﹤0.01% 3360
2024
Q4 		$423K Hold
6,700
– – ﹤0.01% 3661
2024
Q3 		$314K Hold
6,700
– – ﹤0.01% 3751
2024
Q2 		$306K Hold
6,700
– – ﹤0.01% 3757
2024
Q1 		$257K Hold
6,700
– – ﹤0.01% 3856
2023
Q4 		$307K Hold
6,700
– – ﹤0.01% 3790
2023
Q3 		$212K Buy
+6,700
New +$168K ﹤0.01% 3959
2022
Q4 		– Sell
-7,264
Closed -$245K – 4901
2022
Q3 		$245K Buy
+7,264
New +$251K ﹤0.01% 4083

Other funds holding BLTE

Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
High Net Worth Advisory Group
High Net Worth Advisory Group Naples, Florida $476M AUM 15.5% 1-Year Est. Return
Dymon Asia Capital (Singapore)
Dymon Asia Capital (Singapore) Singapore $2.21B AUM 109.09% 1-Year Est. Return
SmartHarvest Portfolios
SmartHarvest Portfolios Poulsbo, Washington $258M AUM 39.79% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Vise Technologies
Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
EverSource Wealth Advisors
EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

Geode Capital Management's BLTE Position: Q3 2026 in Review

Geode Capital Management reduced its Belite Bio (BLTE) stake by 13% in Q3 2026, selling an estimated $494K and leaving 19,596 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #3030.

Geode Capital Management first reported a position in BLTE in Q3 2022 and has held it in 14 quarters since. The position peaked at $3.49M in Q2 2026. 18 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Geode Capital Management held 19,596 shares of Belite Bio worth $3.33M as of Q3 2026.
  • Geode Capital Management sold 3,044 Belite Bio shares in Q3 2026, an estimated $494K.
  • Belite Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3030 holding.
  • Geode Capital Management first reported a position in Belite Bio in Q3 2022 and has held it in 14 quarters since.
  • Geode Capital Management's Belite Bio position peaked at $3.49M in Q2 2026.
  • 18 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.